info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Mycoplasma Testing Market to Grow 13.9% CAGR during the Forecast Period 2022 to 2030

Pune, India, May 2023/MRFR Press Release/- Market Research Future has published a half-cooked research report on the global mycoplasma testing market.


Mycoplasma Testing Market Highlights


The global mycoplasma testing market is anticipated to have held a market value of USD 2.18 billion by 2030 and is expected to grow at a CAGR of 13.9% during the forecast period (2022-2030). Mycoplasma testing used to detect contamination in given biologic sample.


Increasing R&D investment and new product launches are expected to drive the growth of market. According to the Center for Drug Evaluation and Research, in 2017, about 46 novel drug approvals were the 22 novel drug approval in 2016. On other hand, the available of alternative traditional method can restrain the market growth over the assessment period.


Regional Analysis:


Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and growth in pharmaceutical and medical device companies. Europe is expected to hold the second largest position in the global market. Asia-Pacific is expected to be the fastest growing market owing to the increasing adoption of the technologies. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global market.


Segmentation:


The global mycoplasma testing market has been segmented into product, Technique, application, and end user.


Based on product, market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to account for the largest share and fastest growing segment of the global market in 2017.


Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Mycoplasma Testing Market Research Report


Based on technique, market is segmented into Enzyme-based, PCR, ELISA, Direct Assay, Indirect Assay, Others.


Based on application, has been segmented into cell line and cell therapy testing, virus testing, row material testing, lot release testing, and others.


Based on end user, has been segmented into pharmaceutical and biological manufacturing, contract research organizations, cell banks, and others.


Key Players:


Some of the prominent players in the global mycoplasma testing market are Charles River Laboratories, Inc., Merck KGaA, Lonza Group Ltd, Roche Diagnostics, SGS S.A., American Type Culture Collection, Invivogen, Wuxi Apptec, Promocell GmbH, and Thermo Fisher Scientific Inc.


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Report details
Base Year 2023
Companies Covered 15
Pages 100
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.